Immunovia Reports First Quarter Interim Report January – March 2020
LUND, SWEDEN - Immunovia has today published first quarter interim report for January – March 2020. It is available on Immunovia's website . "During Q1 2020, Immunovia worked hard and continued to make great strides towards IMMray™ PanCan-d’s launch and the sales start of the first test for early diagnosis of pancreatic cancer, in spite of the COVID-19 global pandemic. Work on the verification study proceeded as planned and we received all the blood samples from our KOL network. In January, our commercial team prepared detailed plans